RU2595717C2 - Производные трисахаридов и их применение в качестве адъювантов - Google Patents

Производные трисахаридов и их применение в качестве адъювантов Download PDF

Info

Publication number
RU2595717C2
RU2595717C2 RU2013100945/04A RU2013100945A RU2595717C2 RU 2595717 C2 RU2595717 C2 RU 2595717C2 RU 2013100945/04 A RU2013100945/04 A RU 2013100945/04A RU 2013100945 A RU2013100945 A RU 2013100945A RU 2595717 C2 RU2595717 C2 RU 2595717C2
Authority
RU
Russia
Prior art keywords
trisaccharide
acid ester
groups
fatty acid
ester
Prior art date
Application number
RU2013100945/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2013100945A (ru
Inventor
БРЕ Йоханнес Гернардус Матиас Вильхельмус Мария ВАН
Эверардус Йоаннес Петер Мария СХЕНКЕЛАРС
Яуверт Анне ТУРКСТРА
Мария Алдегонда Якоба КРИК
Роберт Патрик Хоф
Вильхельмус Мартинус Мария СХАПЕР
Original Assignee
Иммуново Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иммуново Б.В. filed Critical Иммуново Б.В.
Publication of RU2013100945A publication Critical patent/RU2013100945A/ru
Application granted granted Critical
Publication of RU2595717C2 publication Critical patent/RU2595717C2/ru

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
RU2013100945/04A 2010-06-11 2011-06-03 Производные трисахаридов и их применение в качестве адъювантов RU2595717C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
EP10165707.0 2010-06-11
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (2)

Publication Number Publication Date
RU2013100945A RU2013100945A (ru) 2014-07-20
RU2595717C2 true RU2595717C2 (ru) 2016-08-27

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013100945/04A RU2595717C2 (ru) 2010-06-11 2011-06-03 Производные трисахаридов и их применение в качестве адъювантов

Country Status (25)

Country Link
US (2) US9327020B2 (cg-RX-API-DMAC7.html)
EP (3) EP2397484A1 (cg-RX-API-DMAC7.html)
JP (2) JP6004586B2 (cg-RX-API-DMAC7.html)
KR (1) KR101929973B1 (cg-RX-API-DMAC7.html)
CN (1) CN103154013B (cg-RX-API-DMAC7.html)
AU (1) AU2011262606B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012031440A2 (cg-RX-API-DMAC7.html)
CA (1) CA2802023C (cg-RX-API-DMAC7.html)
CY (1) CY1119704T1 (cg-RX-API-DMAC7.html)
DK (1) DK2580226T3 (cg-RX-API-DMAC7.html)
ES (1) ES2654156T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20171947T1 (cg-RX-API-DMAC7.html)
HU (1) HUE035187T2 (cg-RX-API-DMAC7.html)
IL (1) IL223570A (cg-RX-API-DMAC7.html)
LT (1) LT2580226T (cg-RX-API-DMAC7.html)
MX (1) MX342946B (cg-RX-API-DMAC7.html)
NO (1) NO2580226T3 (cg-RX-API-DMAC7.html)
PL (1) PL2580226T3 (cg-RX-API-DMAC7.html)
PT (1) PT2580226T (cg-RX-API-DMAC7.html)
RS (1) RS56690B1 (cg-RX-API-DMAC7.html)
RU (1) RU2595717C2 (cg-RX-API-DMAC7.html)
SI (1) SI2580226T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201700603T1 (cg-RX-API-DMAC7.html)
WO (1) WO2011155822A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209395B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
HRP20192113T1 (hr) 2014-07-24 2020-02-21 Litevax B.V. Adjuvanti
KR20250052985A (ko) 2023-10-11 2025-04-21 세종대학교산학협력단 삼당류의 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
WO1988006143A1 (en) * 1987-02-11 1988-08-25 Donmarn Limited Anti-scaling compounds
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
EP1792607A1 (en) * 2005-12-01 2007-06-06 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
CZ297431B6 (cs) * 1994-08-04 2006-12-13 Quadrant Holdings Cambridge Limited Prostredek obsahující dodávací systém pevné dávkypro prímou aplikaci v pevné forme a zpusob jeho výroby
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
EP2392579B1 (en) * 2009-02-02 2016-11-23 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
WO1988006143A1 (en) * 1987-02-11 1988-08-25 Donmarn Limited Anti-scaling compounds
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
EP1792607A1 (en) * 2005-12-01 2007-06-06 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Yag G. et al, Organic Letters, 2006, vol. 8, N6, 911-914. P. Arndt et al, Cellulose, Kluwer Academic publishers, DO, 2005, vol. 12, N3, 317-326. Casmir C. Akoh et al, Journal of Food Science, 1987, vol. 52, N6, 1570-1575. Mogemark M et al, Organic & Biomolecular Chemistry, 2003, vol. 1, 2003, 2063-2069. *

Also Published As

Publication number Publication date
RU2013100945A (ru) 2014-07-20
CA2802023A1 (en) 2011-12-15
PT2580226T (pt) 2018-01-05
US9327020B2 (en) 2016-05-03
EP3312188A1 (en) 2018-04-25
ZA201209395B (en) 2014-05-28
LT2580226T (lt) 2018-02-26
AU2011262606B2 (en) 2016-10-27
CN103154013A (zh) 2013-06-12
JP2016216471A (ja) 2016-12-22
BR112012031440A2 (pt) 2017-04-18
CY1119704T1 (el) 2018-06-27
JP6004586B2 (ja) 2016-10-12
US20130273082A1 (en) 2013-10-17
EP2580226A1 (en) 2013-04-17
CN103154013B (zh) 2017-03-15
EP2397484A1 (en) 2011-12-21
KR101929973B1 (ko) 2018-12-18
DK2580226T3 (en) 2018-01-08
IL223570A (en) 2017-03-30
PL2580226T3 (pl) 2018-05-30
KR20130056273A (ko) 2013-05-29
AU2011262606A1 (en) 2013-01-10
HUE035187T2 (hu) 2018-05-02
ES2654156T3 (es) 2018-02-12
MX342946B (es) 2016-10-18
US20170057987A1 (en) 2017-03-02
CA2802023C (en) 2020-07-14
WO2011155822A1 (en) 2011-12-15
SI2580226T1 (en) 2018-04-30
RS56690B1 (sr) 2018-03-30
NO2580226T3 (cg-RX-API-DMAC7.html) 2018-04-28
SMT201700603T1 (it) 2018-03-08
MX2012014422A (es) 2013-08-27
EP2580226B1 (en) 2017-11-29
JP2013528211A (ja) 2013-07-08
HRP20171947T1 (hr) 2018-02-23

Similar Documents

Publication Publication Date Title
JP2648305B2 (ja) 多糖類ワクチン
US20080187553A1 (en) Immunstimulating lipid formulation
FR2598622A1 (fr) Adjuvants immunologiques pour vaccins polysaccharidiques
JP2002537353A (ja) CGモチーフを含むオリゴヌクレオチドを用いるNeisseria抗原殺菌活性の増強
PT988862E (pt) Formulação compreendendo um antigénio, um adjuvante indutor de th-1 e um aminoácido pouco solúvel em água, para utilização em imunização
Norpi et al. New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus
RU2595717C2 (ru) Производные трисахаридов и их применение в качестве адъювантов
Blom et al. Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition
EP3007724A1 (en) Compositions and methods of immunizing against c. difficile
CN114366810B (zh) 一种可高效诱导体液和细胞免疫的天然微生物和植物来源复合双佐剂及其制备方法和应用
US20230102247A1 (en) Methods and compositions relating to ionic liquid adjuvants
WO2024261351A2 (en) Immunologically active saponin fractions and adjuvant formulations
AU2015294769B2 (en) Adjuvants
KR100904226B1 (ko) 레시틴 유사유화제를 함유하는 나노좀 형태의 면역증강제및 그의 백신용 조성물
RU2712750C1 (ru) Амилоидный конъюгат, его применения и способы
Christodoulou et al. Al-fumarate, a Metal-Organic Framework encapsulating antigen as a potent, versatile and resorbable vaccine adjuvant
CA2954043C (en) Carbohydrate ester adjuvants
BR112018016016B1 (pt) Composição farmacêutica compreendendo um conjugado de um ou mais peptídeos cysab (33-40) (seq id no: 1) ligado à hemocianina do molusco keyhole limpet (klh), seu uso, seu método de produção, e ampola de vidro